Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Apple
AAPL
|
+$430M |
| 2 |
Microsoft
MSFT
|
+$312M |
| 3 |
Exxon Mobil
XOM
|
+$258M |
| 4 |
GE Aerospace
GE
|
+$224M |
| 5 |
Johnson & Johnson
JNJ
|
+$221M |
Top Sells
| 1 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$58.7M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$57.9M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$54.7M |
| 4 |
Stellantis
STLA
|
+$26.9M |
| 5 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$20M |
Sector Composition
| 1 | Technology | 14.87% |
| 2 | Healthcare | 14.67% |
| 3 | Consumer Discretionary | 10.51% |
| 4 | Consumer Staples | 10.32% |
| 5 | Industrials | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SSRI
2076
DELISTED
Silver Standard Resources
SSRI
| $752K | ﹤0.01% |
138,900
+29,000
| +26% | +$157K |
|
2077
Mistras Group
MG
$301M
| $751K | ﹤0.01% |
31,300
+5,300
| +20% | +$127K |
|
|
SA
2078
Seabridge Gold
SA
$1.8B
| $751K | ﹤0.01% |
70,500
+13,100
| +23% | +$140K |
|
2079
OraSure Technologies
OSUR
$238M
| $748K | ﹤0.01% |
106,600
+17,300
| +19% | +$121K |
|
2080
Marten Transport
MRTN
$949M
| $747K | ﹤0.01% |
103,375
+19,250
| +23% | +$139K |
|
|
LHCG
2081
DELISTED
LHC Group LLC
LHCG
| $746K | ﹤0.01% |
21,735
+4,000
| +23% | +$137K |
|
|
VA
2082
DELISTED
Virgin America Inc.
VA
| $745K | ﹤0.01% |
19,950
+3,550
| +22% | +$133K |
|
2083
Clearway Energy Class A
CWEN.A
$3.18B
| $744K | ﹤0.01% |
56,750
+10,400
| +22% | +$136K |
|
2084
CBIZ
CBZ
$3.01B
| $743K | ﹤0.01% |
76,300
+14,300
| +23% | +$139K |
|
|
NTK
2085
DELISTED
NORTEK INC COM NEW (DE)
NTK
| $742K | ﹤0.01% |
15,911
+5,611
| +54% | +$262K |
|
2086
CTS Corp
CTS
$1.22B
| $740K | ﹤0.01% |
48,700
+8,900
| +22% | +$135K |
|
|
WMC
2087
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $738K | ﹤0.01% |
7,583
+1,280
| +20% | +$125K |
|
2088
M/I Homes
MHO
$4B
| $737K | ﹤0.01% |
40,900
+7,500
| +22% | +$135K |
|
2089
Shopify
SHOP
$188B
| $737K | ﹤0.01% |
268,000
+173,000
| +182% | +$476K |
|
|
ARNA
2090
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $734K | ﹤0.01% |
38,610
+7,420
| +24% | +$141K |
|
|
AXDX
2091
DELISTED
Accelerate Diagnostics
AXDX
| $733K | ﹤0.01% |
5,270
+920
| +21% | +$128K |
|
2092
Lands' End
LE
$454M
| $733K | ﹤0.01% |
29,710
+5,400
| +22% | +$133K |
|
2093
First Busey Corp
BUSE
$2.19B
| $731K | ﹤0.01% |
37,099
+7,400
| +25% | +$146K |
|
2094
Kadant
KAI
$3.75B
| $731K | ﹤0.01% |
16,800
+3,300
| +24% | +$144K |
|
|
GHDX
2095
DELISTED
Genomic Health, Inc.
GHDX
| $731K | ﹤0.01% |
30,500
+5,400
| +22% | +$129K |
|
2096
Vera Bradley
VRA
$63.7M
| $728K | ﹤0.01% |
37,000
+6,300
| +21% | +$124K |
|
2097
Taylor Morrison
TMHC
$6.89B
| $726K | ﹤0.01% |
53,300
+10,000
| +23% | +$136K |
|
2098
MarineMax
HZO
$545M
| $724K | ﹤0.01% |
38,600
+7,800
| +25% | +$146K |
|
2099
McEwen Inc.
MUX
$742M
| $723K | ﹤0.01% |
39,733
-337
| -0.8% | -$6.13K |
|
2100
CorVel
CRVL
$4.39B
| $720K | ﹤0.01% |
56,700
+9,600
| +20% | +$122K |
|